KIORA PHARMACEUTICALS INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for KIORA PHARMACEUTICALS INC (KPRX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are KPRX insiders buying or selling?
KIORA PHARMACEUTICALS INC insiders reported no open-market purchases or sales in the last 12 months. Since April 2018, Trabud has recorded 36 Form 4 filings for KPRX: 27 buys ($15.8M) and 9 sells ($15.3M).
Source: SEC EDGAR Form 4
Key Statistics (April 2018 – Sep 12, 2024)
Total Form 4 filings
36
SEC EDGAR
Insider filers
16
Insider buys (27)
$15.8M
Insider sells (9)
$15.3M
Insider sentiment
Net buyingNet insider flow of $522.5K in net buying since April 2018.
Recent KPRX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Carmine N. Stengone | Director | Purchase | 1.3K | $3.68 | $4.6K | SEC ↗ |
| Sep 11, 2024 | Aron Shapiro | Director | Purchase | 3.0K | $3.60 | $10.8K | SEC ↗ |
| Aug 20, 2024 | Walters-Hoffert Lisa | Director | Purchase | 1.3K | $3.86 | $4.8K | SEC ↗ |
| Aug 19, 2024 | Praveen Tyle | Director | Purchase | 5.0K | $3.96 | $19.8K | SEC ↗ |
| Aug 15, 2024 | Melissa Tosca | CFO | Purchase | 2.0K | $3.21 | $6.4K | SEC ↗ |
| Jun 14, 2024 | Melissa Tosca | EVP Finance | Purchase | 100 | $5.25 | $525 | SEC ↗ |
| Jun 14, 2024 | Eric Joseph Daniels | Chief Development Officer | Purchase | 1.4K | $5.29 | $7.6K | SEC ↗ |
| Jun 13, 2024 | Erin Parsons | Director | Purchase | 5.3K | $4.88 | $25.7K | SEC ↗ |
| Jun 13, 2024 | Brian M. Strem | President and CEO | Purchase | 3.0K | $5.00 | $15.0K | SEC ↗ |
| Nov 22, 2021 | Brian M. Strem | President and CEO | Purchase | 17.9K | $1.41 | $25.2K | SEC ↗ |
| Aug 3, 2021 | Steven Boyd | 10% Owner | Sale | 261.0K | $2.48 | $646.6K | SEC ↗ |
| Jul 29, 2021 | Steven Boyd | Director, 10% Owner | Sale | 3.2M | $4.61 | $14.5M | SEC ↗ |
| Jan 9, 2021 | Steven Boyd | Director, 10% Owner | Purchase | 1.5M | $5.23 | $8.0M | SEC ↗ |
| Feb 10, 2020 | Steven Boyd | Director, 10% Owner | Purchase | 23.0K | $6.11 | $140.5K | SEC ↗ |
| Dec 6, 2019 | Morton Goldberg | Director | Sale | 2.0K | $6.93 | $13.6K | SEC ↗ |
| Nov 13, 2019 | Morton Goldberg | Director | Sale | 2.0K | $4.29 | $8.6K | SEC ↗ |
| Oct 1, 2019 | Steven Boyd | Director, 10% Owner | Purchase | 605.0K | $3.13 | $1.9M | SEC ↗ |
| Jul 16, 2019 | Sarah Romano | Chief Financial Officer | Sale | 19.8K | $0.24 | $4.7K | SEC ↗ |
| Jul 16, 2019 | MANZO MICHAEL P. | VP of Engineering | Sale | 19.8K | $0.24 | $4.7K | SEC ↗ |
| Jul 16, 2019 | Barbara Wirostko | Chief Medical Officer | Sale | 19.5K | $0.24 | $4.6K | SEC ↗ |
| Jul 16, 2019 | Stephen From | President and CEO | Sale | 127.4K | $0.24 | $30.1K | SEC ↗ |
| Jul 16, 2019 | Brenda Mann | VP of Research & Development | Sale | 19.0K | $0.24 | $4.5K | SEC ↗ |
| Mar 29, 2019 | Steven Boyd | Director, 10% Owner | Purchase | 549.6K | $0.32 | $175.2K | SEC ↗ |
| Dec 12, 2018 | Steven Boyd | Director, 10% Owner | Purchase | 100.4K | $0.40 | $40.3K | SEC ↗ |
| Nov 17, 2018 | Steven Boyd | Director, 10% Owner | Purchase | 360.0K | $0.45 | $161.4K | SEC ↗ |
Showing the 25 most recent of 36 Form 4 filings for KIORA PHARMACEUTICALS INC.
Most active KPRX insiders
- Steven Boyd16 filings
- Brian M. Strem2 filings
- Melissa Tosca2 filings
- Morton Goldberg2 filings
- Sarah Romano2 filings
Ask anything about KPRX insider activity
Use Trabud's AI agent to query KIORA PHARMACEUTICALS INC's Form 4 history in plain English — "Show me KPRX CEO purchases this year" or compare it against any other ticker.
Open the AI agentKPRX insider trading FAQ
Are KIORA PHARMACEUTICALS INC insiders buying or selling?
KIORA PHARMACEUTICALS INC insiders reported no open-market purchases or sales in the last 12 months. Since April 2018, Trabud has recorded 36 Form 4 filings for KPRX: 27 buys ($15.8M) and 9 sells ($15.3M). Over the full record that is net buying of $522.5K.
How many insiders trade KPRX stock?
16 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for KIORA PHARMACEUTICALS INC. The most recent filing was accepted on Sep 12, 2024.
Where does Trabud get KPRX insider trading data?
All KPRX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.